Tametraline (CP-24,441) is the parent of a series of chemical compounds investigated at Pfizer that eventually led to the development of sertraline (CP-51,974-1).

Sertraline has been called "3,4-dichloro-tametraline". This is correct but it is an oversimplification in the sense that sertraline is the S,S-isomer whereas tametraline is the 1R,4S-stereoisomer.

Tametraline

1R-Methylamino-4S-phenyl-tetralin is a potent inhibitor of norepinephrine uptake in rat brain synaptosomes, reverses reserpine induced hypothermia in mice, and blocks uptake of 3H-Norepinephrine into rat heart.

Tametraline

Tametraline is a norepinephrine-dopamine reuptake inhibitor.

Tametraline

Indatraline is an indanamine homolog of tetralin-based tametraline, although in the case of indatraline the product is pm-dichlorinated.

Law

Finland

Tametraline is completely unscheduled.

See also

Cyproheptadine [4-(5H-dibenz-[a,d]cyclohepten-5-ylidine)-1-methylpiperidine]

Dasotraline

Desmethylsertraline

EXP-561 (1-amino-4-phenylbicyclo[2.2.2]octane) JNJ-7925476 Lometraline Nefopam Sertraline

References

1-Aminotetralins

Norepinephrine–dopamine reuptake inhibitors

Pfizer brands

Stimulants